The Scientist - Home

The search for SARS-CoV-2 RNA in 60 saliva samples yielded the same results as conventional nasal swab tests taken from the same patients.

The recent cases come just as Democratic Republic of Congo was set to declare the outbreak’s end.

Researchers are offering tools, equipment, time, and expertise to help alleviate COVID-19 suffering. Here’s how you can chip in.

Calls to include a new breast cancer subtype in future clinical trials reveal fundamental disagreements about HER2’s role in the disease.

Scientists at academic labs equipped to test for SARS-CoV-2 report that multiple barriers are preventing from them from operating at full capacity.

Researchers slowed disease progression in the mice by injecting two different viral vectors, each containing one part of the DNA encoding the Cas9 protein, to edit the causative gene.

A new fossil discovery indicates a second primate group also traversed the Atlantic millions of years ago on a raft of vegetation.

Social distancing measures are based on limited data. As much of the world remains stuck in lockdown, researchers are trying to measure the benefits.

The virus’s tool for prying open host cells is coated in a protective armor of sugar—but gaps may offer vulnerability to disruption by antibodies.

The report by Didier Raoult and colleagues that examined the use of the anti-malarial drug in a small number of COVID-19 patients receives criticism from the very society that published it.

Constantine Stratakis, who was due to lead an institute at McGill University Health Centre, was the subject of eight equal employment opportunity complaints at his last job at the National Institute of Child Health and Human Development.

As the first clinical data become available on treating coronavirus patients with the cells, scientists are equivocal about the rationale for the intervention.